Hertfordshire and West Essex ICB
Prescribing, Policies and Pathways
Prescribing, Policies and Pathways
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Botulinum toxin type A | Focal spasticity, Hemi-facial spasm, Blepharospasm, Cervical dystonia, Frey’s syndrome, Chronic anal fissure, Dysphagia, Hirschsprung’s disease, Overactive bladder,Masseteric hypertrophy and temporomandibular disorders | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Budesonide targeted release (Kinpeygo) | Primary IgA nephrology | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Canagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Dapagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Doxazosin (prolonged release) | Hypertension, benign prostatic hyperplasia (BPH) | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Doxazosin Prolonged-Release Patient Information Leaflet | Hypertension, benign prostatic hyperplasia (BPH) | n/a | Patient information | Hertfordshire and West Essex ICB |
| Empagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Finerenone | Chronic kidney disease | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Patiromer | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Penile Circumcision | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Pentosan polysulfate sodium | Bladder pain syndrome | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Peyronie’s Disease | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Potassium binders | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Reversal of Sterilisation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Roxadustat | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Sodium zirconium | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Tadalafil | Benign prostatic hyperplasia | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tadalafil | Penile rehabilitation | Red | Decision document | Hertfordshire and West Essex ICB |
| Urinary incontinence | Adults | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary Incontinence (UI) | n/a | Clinical pathways | East and North Hertfordshire | |
| Urinary Tract Infections (UTIs) | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Vasectomy | n/a | Clinical policy | Hertfordshire and West Essex ICB |